MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.

Wan L, Tian Y, Zhang R, Peng Z, Sun J, Zhang W

DOI: 10.1002/jcb.26431
Published: 2018 May
Container: Journal of cellular biochemistry
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jcb.26431,
  title = {MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.},
  author = {Wan L and Tian Y and Zhang R and Peng Z and Sun J and Zhang W},
  year = {2018},
  journal = {Journal of cellular biochemistry},
  doi = {10.1002/jcb.26431},
  url = {https://doi.org/10.1002/jcb.26431}
}

RIS

TY  - JOUR
TI  - MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.
AU  - Wan L
AU  - Tian Y
AU  - Zhang R
AU  - Peng Z
AU  - Sun J
AU  - Zhang W
PY  - 2018
JO  - Journal of cellular biochemistry
DO  - 10.1002/jcb.26431
UR  - https://doi.org/10.1002/jcb.26431
ER  -

APA

L, W., Y, T., R, Z., Z, P., J, S., & W, Z. (2018). MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.. Journal of cellular biochemistry. https://doi.org/10.1002/jcb.26431

Source records

pubmed · retrieved 2026-09-25T02:27:42.380Z